© 2005 Oxford University Press
ARTICLE |
Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women
Affiliations of authors: Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School (ATC); Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (ATC, JM, ELG, DJH, CSF); Cancer Epidemiology Program, Dana–Farber/Harvard Cancer Center (ELG, DJH, CSF); Departments of Epidemiology (GJT, ELG, DJH) and Nutrition (ELG, DJH), Harvard School of Public Health; Department of Laboratory Medicine, Children's Hospital (NR); Department of Medical Oncology, Dana–Farber Cancer Institute (CSF), Boston, MA
Correspondence to: Andrew Chan, MD, MPH, Gastrointestinal Unit, Massachusetts General Hospital GRJ-722, Boston, MA 02114 (e-mail: achan{at}partners.org).
Background: Some experimental evidence suggests that iron may play a role in colorectal carcinogenesis, but human data for this role have been conflicting, possibly because of problems related to study design or measurement of iron exposure. We assessed dietary iron intake and genetic and biochemical markers of iron status in a prospective, nested case–control study of women enrolled in the Nurses' Health Study. Methods: Among 32 826 women who provided a blood specimen, we identified 527 women with colorectal adenoma and 527 matched control subjects who underwent endoscopy but were not diagnosed with adenoma after blood collection. We assessed iron intake, mutations in the HFE gene that are associated with hereditary hemochromatosis (i.e., H63D and C282Y), and plasma biochemical measures of total body iron, including transferrin saturation and the ratio of the concentrations of transferrin receptors to ferritin. Logistic regression models were used to estimate relative risks (RR) and 95% confidence intervals (CI). All statistical tests were two-sided. Results: Women with any HFE gene mutation had higher total body iron stores, as reflected by higher transferrin saturations (P<.001) and lower levels of the ratio of transferrin receptors to ferritin (P = .02), than women with no HFE gene mutation. However, HFE gene mutations were not associated with risk of adenoma (multivariable RR = 1.08, 95% CI = 0.83 to 1.39; P = .58). Moreover, comparison of extreme categories showed no associations between adenoma and the extent of transferrin saturation (multivariable RR = 0.96, 95% CI = 0.63 to 1.47; Ptrend = .66), the ratio of transferrin receptors to ferritin (multivariable RR = 0.98, 95% CI, 0.60 to 1.60; Ptrend = .99), or dietary iron intake (multivariable RR = 1.04, 95% CI = 0.68 to 1.57; Ptrend = .94). Conclusions: Although our study used several distinct measures of iron status (i.e., genetic mutations, biochemical markers, and dietary intake) and a nested case–control design, we did not observe a role for iron in the pathogenesis of colorectal neoplasia in women.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Queiroz-Andrade, R. Blasbalg, C. D. Ortega, M. A. M. Rodstein, R. H. Baroni, M. S. Rocha, and G. G. Cerri MR Imaging Findings of Iron Overload RadioGraphics, October 1, 2009; 29(6): 1575 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort Carcinogenesis, May 1, 2008; 29(5): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hazra, S. Chanock, E. Giovannucci, D. G. Cox, T. Niu, C. Fuchs, W. C. Willett, and D. J. Hunter Large-Scale Evaluation of Genetic Variants in Candidate Genes for Colorectal Cancer Risk in the Nurses' Health Study and the Health Professionals' Follow-up Study Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. de Vogel, M. van Engeland, M. Luchtenborg, A. P. de Bruine, G. M. J. M. Roemen, M. H. F. M. Lentjes, R. A. Goldbohm, P. A. van den Brandt, A. F. P. M. de Goeij, and M. P. Weijenberg Dietary Folate and APC Mutations in Sporadic Colorectal Cancer J. Nutr., December 1, 2006; 136(12): 3015 - 3021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Butterworth Another important function for an old friend! The role of iron in colorectal carcinogenesis. Gut, October 1, 2006; 55(10): 1384 - 1386. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Gonder and N. Worm Re: Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition J Natl Cancer Inst, December 7, 2005; 97(23): 1788 - 1788. [Full Text] [PDF]
|
|